A physician-led experiment Steven Klein, an addiction medicine specialist at Caron, is leading a pilot program that represents one of the most extensive real-world tests of GLP-1 drugs for addiction to date
Scientists are working on vaccine for cancer
Our range of non-surgical weight loss injections, including Zepbound, Wegovy and Saxenda, are FDA-approved for obesity management
In addition, as new agents enter the market, payer coverage and prior-authorization landscapes will shiftespecially with expanded medication benefits
Why supervised care matters more with investigational treatment Investigational access carries more uncertainty than established therapies
Depression was the most commonly reported adverse event of the total reports (n = 187